Literature DB >> 23704576

Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Scott G Hansen1, Jonah B Sacha, Colette M Hughes, Julia C Ford, Benjamin J Burwitz, Isabel Scholz, Roxanne M Gilbride, Matthew S Lewis, Awbrey N Gilliam, Abigail B Ventura, Daniel Malouli, Guangwu Xu, Rebecca Richards, Nathan Whizin, Jason S Reed, Katherine B Hammond, Miranda Fischer, John M Turner, Alfred W Legasse, Michael K Axthelm, Paul T Edlefsen, Jay A Nelson, Jeffrey D Lifson, Klaus Früh, Louis J Picker.   

Abstract

CD8(+) T cell responses focus on a small fraction of pathogen- or vaccine-encoded peptides, and for some pathogens, these restricted recognition hierarchies limit the effectiveness of antipathogen immunity. We found that simian immunodeficiency virus (SIV) protein-expressing rhesus cytomegalovirus (RhCMV) vectors elicit SIV-specific CD8(+) T cells that recognize unusual, diverse, and highly promiscuous epitopes, including dominant responses to epitopes restricted by class II major histocompatibility complex (MHC) molecules. Induction of canonical SIV epitope-specific CD8(+) T cell responses is suppressed by the RhCMV-encoded Rh189 gene (corresponding to human CMV US11), and the promiscuous MHC class I- and class II-restricted CD8(+) T cell responses occur only in the absence of the Rh157.5, Rh157.4, and Rh157.6 (human CMV UL128, UL130, and UL131) genes. Thus, CMV vectors can be genetically programmed to achieve distinct patterns of CD8(+) T cell epitope recognition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23704576      PMCID: PMC3816976          DOI: 10.1126/science.1237874

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  66 in total

Review 1.  Chemical and functional analysis of MHC class II-restricted T cell epitopes.

Authors:  C Corradin; A Lanzavecchia
Journal:  Int Rev Immunol       Date:  1991       Impact factor: 5.311

2.  Origin of a T cell clone with a mismatched combination of MHC restriction and coreceptor expression.

Authors:  H Suzuki; K Eshima; Y Takagaki; S Hanaoka; M Katsuki; M Yokoyama; T Hasegawa; S Yamazaki; N Shinohara
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

3.  A roadmap for HLA-DR peptide binding specificities.

Authors:  G Chelvanayagam
Journal:  Hum Immunol       Date:  1997-12       Impact factor: 2.850

4.  MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent.

Authors:  E O Matechak; N Killeen; S M Hedrick; B J Fowlkes
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.

Authors:  Nupur T Pande; Colin Powers; Kwangseog Ahn; Klaus Früh
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

7.  Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.

Authors:  Dominick J Laddy; Jian Yan; Amir S Khan; Hanne Andersen; Amanda Cohn; Jack Greenhouse; Mark Lewis; Jody Manischewitz; Lisa R King; Hana Golding; Ruxandra Draghia-Akli; David B Weiner
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Protein coding content of the UL)b' region of wild-type rhesus cytomegalovirus.

Authors:  Kristie L Oxford; Meghan K Eberhardt; Kai-Wen Yang; Lisa Strelow; Suzanne Kelly; Shan-Shan Zhou; Peter A Barry
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

9.  Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types.

Authors:  Anders E Lilja; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

10.  A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.

Authors:  Erika Assarsson; John Sidney; Carla Oseroff; Valerie Pasquetto; Huynh-Hoa Bui; Nicole Frahm; Christian Brander; Bjoern Peters; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

View more
  246 in total

1.  HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.

Authors:  Weihua Li; Chuanyun Li; Wei Xia; Xiuhui Li
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.

Authors:  Shari N Gordon; Melvin N Doster; Rhonda C Kines; Brandon F Keele; Egidio Brocca-Cofano; Yongjun Guan; Poonam Pegu; Namal P M Liyanage; Monica Vaccari; Nicolas Cuburu; Christopher B Buck; Guido Ferrari; David Montefiori; Michael Piatak; Jeffrey D Lifson; Anastasia M Xenophontos; David Venzon; Marjorie Robert-Guroff; Barney S Graham; Douglas R Lowy; John T Schiller; Genoveffa Franchini
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

Review 3.  A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.

Authors:  Thomas J Hope; Jeanne M Marrazzo
Journal:  AIDS Res Hum Retroviruses       Date:  2015-11       Impact factor: 2.205

4.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

5.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1.

Authors:  Rachel B Gill; J Jason Bowman; Tammy Krogmann; Kurt Wollenberg; David M Asher; Jeffrey I Cohen
Journal:  Virology       Date:  2013-10-02       Impact factor: 3.616

8.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  A CMV vaccine: TREATing despite the TRICKs.

Authors:  Chris A Benedict
Journal:  Expert Rev Vaccines       Date:  2013-10-04       Impact factor: 5.217

10.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.